{"gao_id": "GAO-11-836", "published": "2011-09-23T12:00:00Z", "released": "2011-09-23T08:00:00Z", "summary": "", "title": "Drug Pricing: Manufacturer Discounts in the 340B Program Offer Benefits, but Federal Oversight Needs Improvement", "topics": ["Funds management", "Prices and pricing", "Drugs", "Patient care services", "Hospitals", "Financial analysis", "Health care programs", "Program management", "Medicaid", "Auditing and Financial Management", "Pharmaceutical industry", "Health care services", "Program evaluation", "Compliance", "Stakeholder consultations", "Medicare", "Drug pricing", "Health care reform"], "type": "reports-testimonies", "url": "https://www.gao.gov/products/gao-11-836", "versions": [{"title": "Highlights", "url": "https://www.gao.gov/assets/gao-11-836-highlights.pdf"}, {"title": "Full Report (54 pages)", "url": "https://www.gao.gov/assets/gao-11-836.pdf"}, {"title": "Accessible Text", "url": "https://www.gao.gov/assets/a323707.html"}]}